VTAK Completes Acquisition of Fly Flyte Inc. for 100% Ownership
Catheter Precision, Inc. (VTAK) has acquired the remaining 80.02% equity interest in Fly Flyte, Inc. from Creatd, Inc., achieving full ownership of the AI-enabled regional aviation operator. This acquisition positions VTAK as a leader in regional air mobility, consolidating Flyte’s operations and revenue into VTAK's financial statements. Creatd will receive approximately $6 million in cash and $6 million in Convertible Preferred Stock as part of the transaction.
Theia Market Signal Identification - AI Assisted
Catheter Precision, Inc. (VTAK) has completed the acquisition of 100% of Fly Flyte, Inc., acquiring the remaining 80.02% interest from Creatd, Inc. Flyte, now a wholly owned subsidiary, operates under FAA certification and generates revenue through its fleet of Cirrus Vision Jets.
The acquisition consolidates Flyte's operations and revenue into VTAK, enhancing its growth strategy in regional air mobility. Creatd will receive about $6 million in cash and $6 million in Convertible Preferred Stock in this transaction, while maintaining a significant shareholder position in VTAK.
Comments